Search research articles
Contact Us
Filters
Showing results (31-40 of 451) with videos related to
Page
of 46
Sort By:
Fertility and Sterility
|
March 1, 1981
Homologous artificial insemination after long-term semen cryopreservation
S Friedman, S Broder
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
H Mitsuya, S Broder
The American Journal of Medicine
|
May 21, 1990
Dideoxycytidine: current clinical experience and future prospects. A summary
S Broder, R Yarchoan
Current Topics in Microbiology and Immunology
|
January 1, 1985
Human T-cell leukemia/lymphoma viruses (HTLV): a unique family of pathogenic retroviruses
H Mitsuya, S Broder
Nature
|
February 4, 1987
Strategies for antiviral therapy in AIDS
H Mitsuya, S Broder
Cancer Research
|
February 1, 1993
Trends in program project grant funding at the National Cancer Institute
S Broder, M Cushing
Cancer Research
|
June 15, 1990
Where have traditional competing RO1 grants gone?
S Broder, J Hartinger
Important Advances in Oncology
|
January 1, 1987
Progress in the development of antiviral therapy for HTLV-III-associated diseases
R Yarchoan, S Broder
Immunological Reviews
|
January 1, 1981
In vitro functions of human T cells expressing Fc-IgG or Fc-IgM receptors
W J Pichler, S Broder
The New England Journal of Medicine
|
December 14, 1978
The suppressor-cell network in cancer (second of two parts)
S Broder, T A Waldmann
Page
of 46
Search research articles
Search
Showing results (31-40 of 451) with videos related to
Sort By:
Page
of 46
Fertility and Sterility
|
March 1, 1981
Homologous artificial insemination after long-term semen cryopreservation
S Friedman, S Broder
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
H Mitsuya, S Broder
The American Journal of Medicine
|
May 21, 1990
Dideoxycytidine: current clinical experience and future prospects. A summary
S Broder, R Yarchoan
Current Topics in Microbiology and Immunology
|
January 1, 1985
Human T-cell leukemia/lymphoma viruses (HTLV): a unique family of pathogenic retroviruses
H Mitsuya, S Broder
Nature
|
February 4, 1987
Strategies for antiviral therapy in AIDS
H Mitsuya, S Broder
Cancer Research
|
February 1, 1993
Trends in program project grant funding at the National Cancer Institute
S Broder, M Cushing
Cancer Research
|
June 15, 1990
Where have traditional competing RO1 grants gone?
S Broder, J Hartinger
Important Advances in Oncology
|
January 1, 1987
Progress in the development of antiviral therapy for HTLV-III-associated diseases
R Yarchoan, S Broder
Immunological Reviews
|
January 1, 1981
In vitro functions of human T cells expressing Fc-IgG or Fc-IgM receptors
W J Pichler, S Broder
The New England Journal of Medicine
|
December 14, 1978
The suppressor-cell network in cancer (second of two parts)
S Broder, T A Waldmann
Page
of 46